MMedication Read More As generics wave builds up, Novo Nordisk slashes Ozempic, Wegovy prices | Industry NewsMarch 31, 2026 “It is basically in the injectable space where we have reduced the price because we have…
MMedication Read More What happens if I stop taking GLP-1 s for weight loss?March 28, 2026 This article was reviewed by Mike Bohl, MD. If you’ve been using a GLP-1 such as semaglutide, then…
TTechnology Read More Diverse biobank study links genetics to disease risk and treatmentMarch 28, 2026 A new study by UCLA Health published in Cell presents a major advancement in the future of personalized…
MMedication Read More Ozempic Goes Generic —But Not in the USMarch 23, 2026 A drug that helped turn Novo Nordisk into Europe’s most valuable company is about to lose its…
MMedication Read More Weight Loss Injection For ₹900? Three Pharma Firms Launch Affordable Semaglutide, Check PricesMarch 23, 2026 A new range of lower cost semaglutide injections has been launched in India, offering fresh hope to people…
MMedication Read More GLP-1 RA generics have arrived. Could we buy semaglutide made for just $4?March 23, 2026 Semaglutide is now generic. Just not in Australia. But in China, Brazil and Canada, generic drug makers are…
MMedication Read More Coming Soon: ‘Wegovy HD’March 21, 2026 Federal regulators on Thursday approved a new higher-dose version of the blockbuster obesity drug Wegovy that may…
MMedication Read More What to Know about the Experimental GLP-1 Drug CagriSemaMarch 18, 2026 3 min read THESE DAYS, WHEN it comes to weight loss drugs, you’ve got a veritable buffet of…
HHealth Read More Patients who stop GLP-1 drugs often restart or try alternativesMarch 17, 2026 A large real-world study shows that patients who stop popular GLP-1–based weight-loss drugs often return to treatment or…
MMedication Read More FDA sends letter to Novo Nordisk over potential GLP-1 side effectsMarch 13, 2026 The U.S. Food and Drug Administration sent a warning letter this month to Novo Nordisk, the maker of…
MMedication Read More FDA sends letter to Novo Nordisk over potential GLP-1 side effectsMarch 13, 2026 The U.S. Food and Drug Administration sent a warning letter this month to Novo Nordisk, the maker of…
HHealth Read More Real-world study shows modest weight regain after GLP-1 discontinuationMarch 13, 2026 As the use of injectable GLP-1 drugs continues to rise, questions persist about what happens after patients stop…